About REV-MED
REV-MED is a company based in Seongnam-si (South Korea) founded in 2018. REV-MED offers products and services including TriCell, PRP, PRP UNI, Hilthera 4.0, and OnyRay. REV-MED operates in a competitive market with competitors including Isolere Bio, ExBiome, Zepteon, VIRAPUR and Norgen Biotek, among others.
- Headquarter Seongnam-si, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of REV-MED
REV-MED offers a comprehensive portfolio of products and services, including TriCell, PRP, PRP UNI, Hilthera 4.0, and OnyRay.
Biologic for cell therapy in regenerative medicine applications.
Product for platelet-rich plasma preparation and concentration.
System for unified platelet-rich plasma processing.
Device for advanced cell separation in medical settings.
Equipment for bone marrow and cell concentration.
Tool for autologous cell processing applications.
System for handling patient-derived cells.
Device for dual-cell therapy development.
Product for stromal vascular fraction extraction.
Funding Insights of REV-MED
Detailed funding history for REV-MED
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by REV-MED
Investment portfolio details for REV-MED
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - REV-MED
Detailed financials for REV-MED
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rev-Med Comparisons
Peer comparison for REV-MED
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of REV-MED
REV-MED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Isolere Bio, ExBiome, Zepteon, VIRAPUR and Norgen Biotek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A platform for biotherapeutics purification is provided using TFF technology.
|
|
| Locked | Locked | Locked |
Develops innovative diagnostic technologies for cancer detection from blood samples.
|
|
| Locked | Locked | Locked |
Biomolecular separation tools for antibody potency evaluation are developed.
|
|
| Locked | Locked | Locked |
Provides viral reagents and assay services for scientific and medical research.
|
|
| Locked | Locked | Locked |
Offers kits and services for RNA, DNA extraction, purification, and genomics research.
|
Detailed competitors of REV-MED
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rev-Med
Complete news archive for REV-MED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about REV-MED
REV-MED was founded in 2018.
REV-MED is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
REV-MED was founded in 2018 and is headquartered in Seongnam-si, South Korea. The company operates within the medical or healthcare sector, inferred from its name and domain rev-med.co.kr. Specific details on services, operations, or industry focus remain unavailable. Its location supports regional activities in South Koreas biotech or pharmaceutical landscape, though comprehensive data is limited for investor analysis.
REV-MED's top competitors include Isolere Bio, Zepteon and GenTegra.
REV-MED offers TriCell, PRP, PRP UNI, Hilthera 4.0, and 5 more products and services.